HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Transthoracic and transesophageal follow-up in patients with left atrial thrombosis].

Abstract
The embolic risk and changes of thrombus location and size were investigated in 29 consecutive patients with echocardiographically proven thrombi in the left atrium. Inclusion criteria were the visualization of a left atrial thrombus using transesophageal echocardiography. Transesophageal follow-up echocardiograms were performed at a mean period of 18 months. In this period 6 cases of embolism were observed at an interval of 20 days to 26 months after the detection of thrombus. Thus, the embolic rate was 14% per patient year. All patients received phenprocoumon (n = 4) or aspirin at the time of embolism. Furthermore, in two patients after cardiac thrombectomy left atrial thrombi were seen again although patients were treated with anticoagulants. On the other hand, in 12 patients (5 received oral anticoagulation, 2 received aspirin) thrombi completely resolved. It can be concluded from these data, that the majority of patients receiving anticoagulation profit from this therapy, however, a complete protection against arterial embolism or reoccurrence of thrombi cannot be reached. Left atrial spontaneous echo contrast was the only risk factor significantly associated with thromboembolism in patients with left atrial thrombi.
AuthorsR Zotz, U Pinnau, S Genth, R Erbel, J Meyer
JournalZeitschrift fur Kardiologie (Z Kardiol) Vol. 83 Issue 7 Pg. 474-81 (Jul 1994) ISSN: 0300-5860 [Print] Germany
Vernacular TitleTransthorakale und transösophageale Verlaufsuntersuchung bei Patienten mit linksatrialen Thromben.
PMID7941648 (Publication Type: Journal Article)
Chemical References
  • Phenprocoumon
  • Aspirin
Topics
  • Aged
  • Aspirin (administration & dosage)
  • Combined Modality Therapy
  • Echocardiography
  • Echocardiography, Doppler, Color
  • Echocardiography, Transesophageal
  • Female
  • Follow-Up Studies
  • Heart Atria (diagnostic imaging)
  • Heart Diseases (diagnostic imaging, drug therapy)
  • Humans
  • Male
  • Middle Aged
  • Phenprocoumon (administration & dosage)
  • Recurrence
  • Thrombectomy
  • Thrombosis (diagnostic imaging, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: